Historical review: Molecular and cellular mechanisms of opiate and cocaine addiction

Trends in Pharmacological Sciences

Volumn 25, Issue 4, 2004, Pages 210-218

  Nestler, Eric J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ALCOHOL; AMPHETAMINE; CANNABINOID; COCAINE; DOPAMINE; MONOAMINE; MORPHINE; NALOXONE; NICOTINE; OPIATE; OPIATE ANTAGONIST; PHENCYCLIDINE; PSYCHEDELIC AGENT; PSYCHOSTIMULANT AGENT;

ANIMAL BEHAVIOR; BRAIN; BRAIN REGION; COCAINE DEPENDENCE; DISEASE PREDISPOSITION; DRUG ABUSE; DRUG DEPENDENCE; DRUG EFFECT; DRUG MECHANISM; GENE FUNCTION; GENE IDENTIFICATION; GENETIC PREDISPOSITION; HUMAN; MOLECULAR MECHANICS; NEUROBIOLOGY; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; PROTEIN TARGETING; REVIEW;

ANIMALS; BIOMEDICAL RESEARCH; BRAIN; COCAINE-RELATED DISORDERS; CYCLIC AMP; HISTORY, 20TH CENTURY; HUMANS; MOLECULAR BIOLOGY; MORPHINE; NEUROBIOLOGY; OPIOID-RELATED DISORDERS; UP-REGULATION;

EID: 1942517856     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2004.02.005     Document Type: Review

References (101)

1. Gainetdinov R.R., Caron M.G. Monoamine transporters: from genes to behavior. Annu. Rev. Pharmacol. Toxicol. 43:2003;261-284.
2. Snyder S.H., Pasternak G.W. Historical review: opioid receptors. Trends Pharmacol. Sci. 24:2003;198-205.
3. Whistler J.L., et al. Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction. Neuron. 23:1999;737-746.
4. Bohn L.M., et al. μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence. Nature. 408:2000;720-723.
5. Nestler E.J., Greengard P. Protein Phosphorylation in the Nervous System. 1984;J. Wiley & Sons.
6. Sharma S.K., et al. Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc. Natl. Acad. Sci. U. S. A. 72:1975;3092-3096.
7. Collier H.O., Francis D.L. Morphine abstinence is associated with increased brain cyclic AMP. Nature. 255:1975;159-162.
8. Aghajanian G.K. Tolerance of locus coeruleus neurons to morphine and suppression of withdrawal response by clonidine. Nature. 276:1978;186-188.
9. Alreja M., Aghajanian G.K. Pacemaker activity of locus coeruleus neurons: whole-cell recordings in brain slices show dependence on cAMP and protein kinase A. Brain Res. 556:1991;339-343.
10. Nestler E.J., Tallman J.F. Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus coeruleus. Mol. Pharmacol. 33:1988;127-132.
11. Duman R.S., et al. Acute and chronic opiate regulation of adenylate cyclase in brain: Specific effects in locus coeruleus. J. Pharmacol. Exp. Ther. 246:1988;1033-1039.
12. Guitart X., Nestler E.J. Identification of morphine- and cyclic AMP-regulated phosphoproteins (MARPPs) in the locus coeruleus and other regions of rat brain: regulation by acute and chronic morphine. J. Neurosci. 9:1989;4371-4387.
13. Matsuoka I., et al. Chronic morphine administration causes region-specific increase of brain type VIII adenylyl cyclase mRNA. Eur. J. Pharmacol. 268:1994;215-221.
14. Lane-Ladd S.B., et al. CREB (cAMP response element-binding protein) in the locus coeruleus: Biochemical, physiological, and behavioral evidence for a role in opiate dependence. J. Neurosci. 17:1997;7890-7901.
15. Taylor J.R., et al. Clonidine infusions into the locus coeruleus attenuate behavioral and neurochemical changes associated with naloxone-precipitated withdrawal. Psychopharmacology (Berl.). 96:1988;121-134.
16. Koob G.F., et al. Neural substrates of opiate withdrawal. Trends Neurosci. 15:1992;186-191.
17. Maldonado R., Koob G.F. Destruction of the locus coeruleus decreases physical signs of opiate withdrawal. Brain Res. 605:1993;128-138.
18. Delfs J.M., et al. Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature. 403:2000;430-434.
19. Rasmussen K., et al. Opiate withdrawal and the rat locus coeruleus: Behavioral, electrophysiological, and biochemical correlates. J. Neurosci. 10:1990;2308-2317.
20. Kogan J.H., et al. Elevated basal firing rates and enhanced responses to 8-Br-cAMP in locus coeruleus neurons in brain slices from opiate-dependent rats. Eur. J. Pharmacol. 211:1992;47-53.
21. Maldonado R., et al. Protein kinases in the locus coeruleus and periaqueductal gray matter are involved in the expression of opiate withdrawal. Naunyn Schmiedebergs Arch. Pharmacol. 352:1995;565-575.
22. Punch L., et al. Opposite modulation of opiate withdrawal behaviors upon microinfusion of a protein kinase A inhibitor versus activator into the locus coeruleus or periaqueductal gray. J. Neurosci. 17:1997;8520-8527.
23. Aston-Jones G., et al. Local opiate withdrawal in locus coeruleus in vivo. Brain Res. 765:1997;331-336.
24. Christie M.J., et al. Where is the locus in opioid withdrawal? Trends Pharmacol. Sci. 18:1997;134-140.
25. Gold M.S., et al. Clonidine blocks acute opiate withdrawal symptoms. Lancet. 2:1978;599-602.
26. Terwilliger R.Z., et al. A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res. 548:1991;100-110.
27. Bonci A., Williams J.T. Increased probability of GABA release during withdrawal from morphine. J. Neurosci. 17:1997;796-803.
28. Nestler E.J., Aghajanian G.K. Molecular and cellular basis of addiction. Science. 278:1997;58-63.
29. Jentsch J.D., et al. Stimulation of protein kinase A activity in the rat amygdala enhances reward-related learning. Biol. Psychiatry. 52:2002;111-118.
30. Nestler E.J. Molecular basis of neural plasticity underlying addiction. Nat. Rev. Neurosci. 2:2001;119-128.
31. Guitart X., et al. Regulation of cAMP response element-binding protein phosphorylation by acute and chronic morphine in the rat locus coeruleus. J. Neurochem. 58:1992;1168-1171.
32. Widnell K.L., et al. Regulation of expression of cAMP response element binding protein in the locus coeruleus in vivo and in a locus coeruleus-like (CATH.a) cell line in vitro. Proc. Natl. Acad. Sci. U. S. A. 91:1994;10947-10951.
33. Shaw-Lutchman T.Z., et al. Regional and cellular mapping of cAMP response element-mediated transcription during naltrexone-precipitated morphine withdrawal. J. Neurosci. 22:2002;3663-3672.
34. Han M.-H., et al. Direct evidence for a role of CREB in the locus coeruleus in opiate dependence. Soc. Neurosci. Abstr. 29:2003;644.6.
35. Maldonado R., et al. Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB. Science. 273:1996;657-659.
36. American Psychiatric Association. Diagnostic and Statistical Manual. 2000;American Psychiatric Press.
37. Olds M.E. Reinforcing effects of morphine in the nucleus accumbens. Brain Res. 237:1982;429-440.
38. Kuhar M.J., et al. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci. 14:1991;299-302.
39. Koob G.F., et al. Neuroscience of addiction. Neuron. 21:1998;467-476.
40. Wise R.A. Drug-activation of brain reward pathways. Drug Alcohol Depend. 51:1998;13-22.
41. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U. S. A. 85:1988;5274-5278.
42. Everitt B.J., Wolf M.E. Psychomotor stimulant addiction: a neural systems perspective. J. Neurosci. 22:2002;3312-3320.
43. Kelley A.E., Berridge K.C. The neuroscience of natural rewards: relevance to addictive drugs. J. Neurosci. 22:2002;3306-3311.
44. Sawin E.R., et al. C. elegans locomotory rate is modulated by the environment through a dopaminergic pathway and by experience through a serotonergic pathway. Neuron. 26:2000;619-631.
45. McClung C., Hirsh J. Stereotypic behavioral responses to free-base cocaine and the development of behavioral sensitization in Drosophila. Curr. Biol. 8:1998;109-112.
46. Nestler E.J., et al. Neurobiology of depression. Neuron. 34:2002;13-25.
47. Shaham Y., et al. Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res. Rev. 33:2000;13-33.
48. Markou A., et al. Animal models of drug craving. Psychopharmacology (Berl.). 112:1993;163-182.
49. 2-like dopamine receptor agonists. Science. 271:1996;1586-1589.
50. Baker D.A., et al. Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nat. Neurosci. 6:2003;743-774.
51. Burns L.H., et al. Effects of lesions to amygdala, ventral subiculum, medial prefrontal cortex, and nucleus accumbens on the reaction to novelty: implication for limbic-striatal interactions. Behav. Neurosci. 110:1996;60-73.
52. White F.J., Kalivas P.W. Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend. 51:1998;141-153.
53. Kalivas P.W., Nakamura M. Neural systems for behavioral activation and reward. Curr. Opin. Neurobiol. 9:1999;223-227.
54. Volkow N.D., Fowler J.S. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb. Cortex. 10:2000;318-325.
55. Ortiz J., et al. Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine system. Synapse. 21:1995;289-298.
56. Shaw-Lutchman T.Z., et al. Regulation of CRE-mediated transcription in mouse brain by amphetamine. Synapse. 48:2003;10-17.
57. Cole R.L., et al. Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron. 14:1995;813-823.
58. Asher O., et al. Ethanol stimulates cAMP-responsive element (CRE)-mediated transcription via CRE-binding protein and cAMP-dependent protein kinase. J. Pharmacol. Exp. Ther. 301:2002;66-70.
59. Carlezon W.A. Jr, et al. Regulation of cocaine reward by CREB. Science. 282:1998;2272-2275.
60. Self D.W., et al. Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior. J. Neurosci. 18:1998;1848-1859.
61. Pliakas A.M., et al. Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in the nucleus accumbens. J. Neurosci. 21:2001;7397-7403.
62. Walters C.L., Blendy J.A. Different requirements for cAMP response element binding protein in positive and negative reinforcing properties of drugs of abuse. J. Neurosci. 21:2001;9438-9444.
63. Barrot M., et al. CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proc. Natl. Acad. Sci. U. S. A. 99:2002;11435-11440.
64. Newton S.S., et al. Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect. J. Neurosci. 22:2002;10883-10890.
65. McClung C.A., Nestler E.J. Regulation of gene expression and cocaine reward by CREB and ΔFosB. Nat. Neurosci. 11:2003;1208-1215.
66. Shippenberg T.S., Rea W. Sensitization to the behavioral effects of cocaine: modulation by dynorphin and kappa-opioid receptor agonists. Pharmacol. Biochem. Behav. 57:1997;449-455.
67. Butelman E.R., et al. GR89,696: a potent kappa-opioid agonist with subtype selectivity in rhesus monkeys. J. Pharmacol. Exp. Ther. 298:2001;1049-1059.
68. Nestler E.J. Molecular mechanisms of drug addiction. J. Neurosci. 12:1992;2439-2450.
69. Striplin C.D., Kalivas P.W. Correlation between behavioral sensitization to cocaine and G protein ADP-ribosylation in the ventral tegmental area. Brain Res. 579:1992;181-186.
70. Hanson G.R., et al. Responses of limbic and extrapyramidal neurotensin systems to stimulants of abuse. Involvement of dopaminergic mechanisms. Ann. New York Acad. Sci. 668:1992;165-172.
71. Fitzgerald L.W., et al. Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents. J. Neurosci. 16:1996;274-282.
72. Carlezon W.A. Jr, Nestler E.J. Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse? Trends Neurosci. 25:2002;610-615.
73. Graybiel A.M., et al. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. U. S. A. 87:1990;6912-6916.
74. Young S.T., et al. Cocaine induces striatal c-fos-immunoreactive proteins via dopaminergic D1 receptors. Proc. Natl. Acad. Sci. U. S. A. 88:1991;1291-1295.
75. Hope B., et al. Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine. Proc. Natl. Acad. Sci. U. S. A. 89:1992;5764-5768.
76. Hope B.T., et al. Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron. 13:1994;1235-1244.
77. Chen J.S., et al. Regulation of ΔFosB and FosB-like proteins by electroconvulsive seizure and cocaine treatments. Mol. Pharmacol. 48:1995;880-889.
78. Chen J., et al. Chronic Fos-related antigens: stable variants of ΔFosB induced in brain by chronic treatments. J. Neurosci. 17:1997;4933-4941.
79. Hiroi N., et al. FosB mutant mice: loss of chronic cocaine induction of Fos-related proteins and heightened sensitivity to cocaine's psychomotor and rewarding effects. Proc. Natl. Acad. Sci. U. S. A. 94:1997;10397-10402.
80. Nye H., et al. Pharmacological studies of the regulation of chronic Fos-related antigen induction by cocaine in the striatum and nucleus accumbens. J. Pharmacol. Exp. Ther. 275:1995;1671-1680.
81. Moratalla R., et al. Network-level changes in expression of inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal. Neuron. 17:1996;147-156.
82. Nye H.E., Nestler E.J. Induction of chronic Fos-related antigens in rat brain by chronic morphine administration. Mol. Pharmacol. 49:1996;636-645.
83. Pich E.M., et al. Common neural substrates for the addictive properties of nicotine and cocaine. Science. 275:1997;83-86.
84. Werme M., et al. ΔFosB regulates wheel running. J. Neurosci. 22:2002;8133-8138.
85. Nestler E.J., et al. ΔFosB: a molecular switch for addiction. Proc. Natl. Acad. Sci. U. S. A. 98:2001;11042-11046.
86. Kelz M.B., et al. Expression of the transcription factor ΔFosB in the brain controls sensitivity to cocaine. Nature. 401:1999;272-276.
87. Peakman M.C., et al. Inducible, brain region specific expression of a dominant negative mutant of c-Jun in transgenic mice decreases sensitivity to cocaine. Brain Res. 970:2003;73-86.
88. Colby C.R., et al. Striatal cell type-specific overexpression of delta-FosB enhances incentive for cocaine. J. Neurosci. 23:2003;2488-2493.
89. Zachariou V., et al. ΔFosB in the nucleus accumbens modulates morphine reward, tolerance, and dependence. Soc. Neurosci. Abstr. 29:2003;112.16.
90. Olausson P., et al. Enhanced incentive motivation in ΔFosB overexpressing mice. Soc. Neurosci. Abstr. 28:2002;502-514.
91. Sklair-Tavron L., et al. Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc. Natl. Acad. Sci. U. S. A. 93:1996;11202-11207.
92. Robinson T.E., Kolb B. Morphine alters the structure of neurons in the nucleus accumbens and neocortex of rats. Synapse. 33:1999;160-162.
93. Robinson T.E., Kolb B. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J. Neurosci. 17:1997;8491-8497.
94. Bibb J.A., et al. Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature. 410:2001;376-380.
95. Norrholm S.D., et al. Cocaine-induced proliferation of dendritic spines in nucleus accumbens is dependent on the activity of cyclin-dependent kinase-5. Neuroscience. 116:2003;19-22.
96. Berke J.D., Hyman S.E. Addiction, dopamine, and the molecular mechanisms of memory. Neuron. 25:2000;515-532.
97. Hyman S.E., Malenka R.C. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat. Rev. Neurosci. 2:2001;695-703.
98. Nestler E.J. Common molecular and cellular substrates of addiction and memory. Neurobiol. Learn. Mem. 78:2002;637-647.
99. Jones S., et al. Amphetamine blocks long-term synaptic depression in the ventral tegmental area. J. Neurosci. 20:2000;5575-5580.
100. Thomas M.J., et al. Long-term depression in the nucleus accumbens: a neural correlate of behavioral sensitization to cocaine. Nat. Neurosci. 4:2001;1217-1223.
101. Saal D., et al. Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron. 37:2003;577-582.